[French validation of a Minor Morphologic Anomalies Scale in schizophrenic patients and their parents]

D Gourion1, G Viot, C Goldberger

  • 1SHU, Laboratoire Universitaire de Psychiatrie Biologique (EA 2501), UP V, Hôpital Sainte-Anne, 7, rue Cabanis, 75014 Paris.

L'Encephale
|June 16, 2001
PubMed

Insights

Minor Physical Anomalies are linked to neurodevelopmental disorders like schizophrenia. A validated French scale reliably identifies these anomalies in patients and their parents, supporting the neurodevelopmental model.

Area of Science:

  • Neurodevelopmental disorders
  • Psychiatry
  • Genetics

Background:

  • Minor Physical Anomalies (MPAs) are indicators of early neurodevelopmental disturbances.
  • MPAs are frequently observed in various brain disorders, including schizophrenia.
  • A validated scale for MPA assessment in adult psychiatric patients, particularly those with schizophrenia, is needed.

Purpose of the Study:

  • To revise and validate a French version of a scale for evaluating Minor Physical Anomalies in adult psychiatric patients.
  • To assess the scale's reliability and utility in identifying neurodevelopmental markers in schizophrenia.

Main Methods:

  • Revision of the Waldrop scale, focusing on frequency, adult reliability, and rating consistency.
  • Inclusion of new items related to known syndromes with behavioral symptoms.
  • Evaluation of inter-rater reliability between two blind examiners after a brief training period.

Main Results:

  • The revised French MPA scale demonstrated good inter-rater reliability (Intraclass Correlation Coefficient = 0.97).
  • Schizophrenia patients exhibited significantly more MPAs than control subjects and their parents.
  • Parents of schizophrenia patients also showed significantly more MPAs than normal control subjects.

Conclusions:

  • The revised French MPA scale is a reliable tool for assessing neurodevelopmental markers in psychiatric patients, especially schizophrenia.
  • The scale effectively differentiates schizophrenia patients from their parents and controls.
  • Findings support the neurodevelopmental hypothesis of schizophrenia and highlight the scale's utility in pathophysiological studies.
Abstract